Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on European Global Times.
Press releases published on March 17, 2025
Maxion Therapeutics Raises $72 million (£58 million) in an Oversubscribed Series A Financing to Advance its KnotBody® Pipeline and Platform
GlobeNewswire
·
March 17, 2025
Maxion Therapeutics Raises $72 million (£58 million) in an Oversubscribed Series A Financing to Advance its KnotBody® Pipeline and Platform Financing led by General Catalyst with additional investment from new investors, British Patient Capital, Solasta …
Allarity Therapeutics Announces Presentation of Phase 2 Clinical Data from Ongoing Trial in Advanced Ovarian Cancer Patients at the 2025 Annual Meeting for the Society of Gynecologic Oncology
GlobeNewswire
·
March 17, 2025
The Annual Meeting is the foremost educational and scientific event for gynecologic oncologists Stenoparib has shown clinical benefit in heavily pre-treated patients, including those with platinum-resistant and refractory ovarian cancer Findings may …
Enlivex Receives Notice of Allowance for Chinese Patent Application Covering the Use of Allocetra in Patients with Osteoarthritis
GlobeNewswire
·
March 17, 2025
Nes-Ziona, Israel, March 17, 2025 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced that the China National Intellectual Property Administration ( …
atai Life Sciences Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights
GlobeNewswire
·
March 17, 2025
- Dosed the first patient in the Phase 2 Elumina trial of VLS-01 (buccal film DMT) for patients with treatment-resistant depression; topline data anticipated in Q1’26 - Initiated a Phase 2 clinical trial of EMP-01 (oral R-MDMA) for patients with social …
Tiziana Life Sciences to Present at the 37th Annual Roth Conference
GlobeNewswire
·
March 17, 2025
NEW YORK, March 17, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a …
Sailing: curtain falls on the 'Virginie Hériot Trophy' at Yacht Club de Monaco
GlobeNewswire
·
March 17, 2025
MONACO, March 17, 2025 (GLOBE NEWSWIRE) -- Another intense edition of the 'Virginie Hériot Trophy', the prestigious all-female sailing competition organized by the Yacht Club de Monaco, has come to an end. For three days, 21 teams from nine nations …
American Tungsten Corp. Announces Intention to Commence Normal Course Issuer Bid
GlobeNewswire
·
March 17, 2025
Vancouver, British Columbia, March 17, 2025 (GLOBE NEWSWIRE) -- American Tungsten Corp. (CSE:TUNG) (OTCQB:DEMRF) (FSE:RK9) (“American Tungsten” or the "Company") is pleased to announce its intention to commence a normal course issuer bid (the “NCIB”), …
Zenas BioPharma Appoints Lisa von Moltke, M.D., as Head of Research and Development and Chief Medical Officer
GlobeNewswire
·
March 17, 2025
–Dr. von Moltke brings over 30 years of deep drug development experience and a proven track record of clinical and regulatory success at both large and emerging global biopharmaceutical companies– WALTHAM, Mass., March 17, 2025 (GLOBE NEWSWIRE) -- Zenas …
GROUPE COURTIN ANNONCE LA NOMINATION DE JEAN MICHEL ROYO A SON CONSEIL STRATEGIQUE
GlobeNewswire
·
March 17, 2025
Le Groupe Courtin annonce l’arrivée de Jean-Michel Royo au sein de son Conseil stratégique. Fort d’une vaste expérience dans les secteurs bancaires, du logement, des collectivités locales et des entreprises, Jean-Michel Royo apportera une expertise …
Travere Therapeutics Submits sNDA to FDA for Approval of FILSPARI® (sparsentan) for the Treatment of FSGS
GlobeNewswire
·
March 17, 2025
sNDA submission based on results from Phase 3 DUPLEX and Phase 2 DUET studies of FILSPARI in FSGS If approved, FILSPARI could become the first and only FDA-approved treatment for FSGS, a rare kidney condition and a leading cause of kidney failure …
Humanetics Selects Lifecore Biomedical to Deliver CDMO Services Supporting Development of BIO 300 for the Prevention of Acute Radiation Syndrome
GlobeNewswire
·
March 17, 2025
Humanetics’ Novel Radioprotective Agent Being Developed with Funding from Department of Defense as Radiation Medical Countermeasure (MCM) Lifecore to Carry Out Tech Transfer and Analytical Method Activities, including Filling of Pilot Batch CHASKA, Minn. …
Greenheart Gold Provides an Update on Its Exploration Projects in Guyana
GlobeNewswire
·
March 17, 2025
Expansion of exploration ground in the Tamakay area Preliminary work on the 55 sq km Tamakay project indicates several areas of anomalous grab and soil samples including a 1,500 m by 750 m soil anomaly within the volcano-sedimentary rock units At Abuya, …
Precore Gold Corp. (formerly, Double Deuce Exploration Corp.): Change of Name and Trading Symbol
GlobeNewswire
·
March 17, 2025
VANCOUVER, British Columbia, March 17, 2025 (GLOBE NEWSWIRE) -- Precore Gold Corp. (formerly, Double Deuce Exploration Corp.) (CSE-DD) (the “Company”) is pleased to announce that it has changed its name from “Double Deuce Exploration Corp.” to “Precore …
Axi weźmie udział w Invest Cuffs 2025 w Polsce
GlobeNewswire
·
March 17, 2025
SYDNEY, March 17, 2025 (GLOBE NEWSWIRE) -- Czołowy internetowy broker FX i CFD Axi ogłosił swój udział w tegorocznych targach Invest Cuffs w Krakowie, w Polsce, które odbędą się w dniach 28–29 marca 2025 r. w Centrum Kongresowym ICE Kraków. Uczestnicy …
Ortus Energy and SSE Energy Solutions drive solar adoption at KIA Stockton
GlobeNewswire
·
March 17, 2025
STOCKTON-ON-TEES, United Kingdom, March 17, 2025 (GLOBE NEWSWIRE) -- Ortus Energy, in partnership with SSE Energy Solutions, is pleased to announce the development of a significant solar energy project at the Kia Stockton dealership, in Stockton-On-Tees. …
International Petroleum Corporation Announces Results of Normal Course Issuer Bid
GlobeNewswire
·
March 17, 2025
TORONTO, March 17, 2025 (GLOBE NEWSWIRE) -- International Petroleum Corporation (IPC or the Corporation) (TSX, Nasdaq Stockholm: IPCO) is pleased to announce that IPC repurchased a total of 339,400 IPC common shares (ISIN: CA46016U1084) during the period …
AEG Global Partnerships Appoints Vice President for the Middle East
GlobeNewswire
·
March 17, 2025
London, UK, March 17, 2025 (GLOBE NEWSWIRE) -- AEG Global Partnerships, a division of AEG, the world’s leading sports and live entertainment company, has appointed Fadi Zouein to the role of Vice President, Global Partnerships, Middle East. In the newly …
RRJ Joins Vista With $600m Equity Investment
GlobeNewswire
·
March 17, 2025
RRJ JOINS VISTA WITH $600M EQUITY INVESTMENT RRJ Capital leads global consortium of esteemed backers Vista, the world’s leading global private aviation group, has signed a definitive agreement for an equity investment of $600 million from a consortium of …
XRPTurbo Presale Nears 100,000 XRP Milestone as Investor Interest Surges Amid Market Volatility
GlobeNewswire
·
March 17, 2025
TALLINN, Estonia, March 17, 2025 (GLOBE NEWSWIRE) -- XRPTurbo, a Web3 launchpad built on the XRP Ledger (XRPL), is on the verge of reaching a key milestone, with its ongoing presale approaching 100,000 XRP raised. This milestone comes amid recent market …
Vilnius erhält höchste Auszeichnung für seine Anlagestrategie
GlobeNewswire
·
March 17, 2025
VILNIUS, Litauen, March 17, 2025 (GLOBE NEWSWIRE) -- Go Vilnius gibt bekannt, dass die Stadt Vilnius im Ranking „Mittelgroße europäische Städte der Zukunft 2025“ von fDi die Auszeichnung für die beste Strategie für ausländische Direktinvestitionen erhalten …